ADIAL PHARMACEUTICALS, INC. — Director's Dealing 2020

Mar 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK: 0001513525
Period of Report: 2020-03-03

Reporting Person: Anderson J. Kermit (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-03	Stock Option	$1.44	A	60000	Acquired	2030-03-02	Common Stock (60000)	Direct

Footnotes

F1: The option vests pro rata on a monthly basis over 36 months.